The
American Society of Hematology’s update arrived today. It focussed on
haemostasis:
 |
Heparin-Induced Thrombocytopenia Does Not Appear to Protect Against Major Bleeding Results published in the Journal of Thrombosis and Haemostasis suggest no difference in bleeding risk between people with suspected HIT and those without. |
 |
Older Patients with iTTP Have Delayed Diagnosis and Higher Mortality Than Younger Counterparts The atypical presentation of immune thrombotic thrombocytopenic purpura in older adults can lead to delays in diagnosis, contributing to their worse prognosis. |
 |
Breakthroughs for Bleeding: Updates in Treating and Managing Hemophilia Experts review the new therapies in clinical use and in development for patients with hemophilia, from extended half-life recombinant factor products to RNA interference therapies. |
No comments:
Post a Comment